Virulence Genes Profile of Multidrug Resistant Pseudomonas aeruginosa Isolated from Iranian Children with UTIs
Abstract
Virulent and resistant strains Pseudomonas aeruginosa (P. aeruginosa) is one of the most important cause of UTIs in pediatrics. The present study was carried to investigate the frequency of virulence factors in the multi-drug resistant strains of P. aeruginosa isolated from pediatrics hospitalized due to the UTIs. One - hundred and forty three urine samples were collected from pediatric patients suffered from UTIs. Samples were cultured and those that were P. aeruginosa positive were analyzed for the presence of putative virulence genes. Seventy one out of 143 samples (49.65%) were positive for P. aeruginosa. Monthly, sex and age-dependent prevalence were seen for P. aeruginosa. Bacterial strains had the highest levels of resistance against ampicillin (95.77%), gentamicin (92.95%) and ciprofloxacin (81.69%). Of 71 P. aeruginosa isolates, 12 strains were resistant to more than 9 antibiotics (16.90%). The most commonly detected virulence factors in the cases of urethral infections were exoU and plcH while those of pyelonephritis and cystitis were were exoS and lasB. Our findings should raise awareness about antibiotic resistance in hospitalized pediatrics with UTIs in Iran. Clinicians should exercise caution in prescribing antibiotics, especially in cases of UTIs. Such information can help in identifying these virulence genes as useful diagnostic markers for clinical P. aeruginosa strains isolated from UTIs.
Mittal R, Aggarwal S, Sharma S, et al. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. J Infect Public Health 2009;2(3):101-11.
Momtaz H, Karimian A, Madani M, et al. Uropathogenic Escherichia coli in Iran: Serogroup distributions, virulence factors and antimicrobial resistance properties. ACMA 2013;12(1):8.
Dormanesh B, Safarpoor Dehkordi F, Hosseini Se, t al. Virulence factors and o-serogroups profiles of uropathogenic Escherichia coli isolated from Iranian pediatric patients. Iran Red Crescent Med J 2014;16(2):e14627.
Yahaghi E, Imani Fooladi AA, Amin M, et al. Detection of Class I Integrons in Staphylococcus aureus Isolated From Clinical Samples. Iranian Red Crescent MedJ;16(11):e16234.
Shaikh N, Morone NE, Bost JE, et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008;27(4):302-8.
Sobczyk D, Krynicki T, Blumczyński A, et al. New, successful treatment of urinary tract infection caused by Pseudomonas aeruginosa. Przegl Lek 2006;63(Suppl3):140-1.
Fu XH, Zhou W, Zhang XM, et al. Clinical analysis of 22 cases community-acquired Pseudomonas aeruginosa urinary tract infection. Zhonghua Er Ke Za Zhi 2013;51(4):298-301.
Ra'oof WM. Distribution of algD, lasB, pilB and nan1 genes among MDR clinical isolates of Pseudomonas aeruginosa in respect to the site of infection. Tikrit Med J 2011;17(2):148-60.
Rashno Taee S, Khansarinejad B, Abtahi H, et al. Detection of algD, oprL and exoA Genes by New Specific Primers as an Efficient, Rapid and Accurate Procedure for Direct Diagnosis of Pseudomonas aeruginosa Strains in Clinical Samples. Jundishapur J Microbiol 2014;7(10):e13583.
Lister PD, Wolter DJ, Hanson ND. Antibacterial- Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanism. Clin Microbiol Rev 2009;22(4):582-610.
Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011;86(3):250-9.
Narten M, Rosin N, Schobert M, et al. Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Curr Microbiol 2012;64(1):7-16.
MacKenzie JR, Fowler K, Hollman AS, et al. The value of ultrasound in the child with an acute urinary tract infection. Br J Urol 1994;74(2):240-4.
National Collaborating Centre for Women's and Children's Health (UK). Urinary Tract Infections in Children: Diagnosis, Treatment and Long-term Management. RCOG Press 2007.
Lavenir R, Jocktane D, Laurent F, et al. Improved reliability of Pseudomonas aeruginosa PCR detection bythe use of the species-specific ecfX gene target. J Microbiol Methods 2007;70(1):20-9.
Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement, Clinical and Laboratory Standards Institute (CLSI); 2008.
Sambrok JA, editor. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press: p. 2100.
Strateva T. Microbiological and molecular-genetic investigations on resistance mechanisms and virulence factors in clinical strains of Pseudomonas aeruginosa [Dissetation]. Medical Univ of Sofia, Bulgaria, 2008.
Lanotte P, Watt S, Mereghetti L, et al. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from otherorigins. J Med Microbiol 2004;53(Pt 1):73-81.
Nandi A, Bhattacharya S, Biswas S, et al. A study on Metallo-β lactamase producing Imepenem nonsusceptible multi-drug resistant Pseudomonas aeruginosa in different clinical specimens in a tertiary care hospital in Kolkata. J Dent Med Sci 2014;13(6):13-7.
Haghi-Ashteiani M, Sadeghifard N, Abedini M, et al. Etiology and antibacterial resistance of bacterial urinary tract infections in children’s medical center, Tehran, Iran. Acta Med Iran 2007;45(2):153-57.
Maji SK, Maity C, Halder SK, et al. Studies on Drug Sensitivity and Bacterial Prevalence of UTI in Tribal Population of Paschim Medinipur, West Bengal, India. Jundishapur J Microbiol 2013;6(1):42-6.
Mirsoleymani SR, Salimi M, Shareghi Brojeni M, et al. Bacterial Pathogens and Antimicrobial Resistance Patterns in Pediatric Urinary Tract Infections: A Four- Year Surveillance Study (2009–2012). Int J Pediatr 2014;2014:1-6.
Abaeze S, Abasiama JS. The prevalence of urinary catheter related infections in federal medical centre Abeokuta Nigeria. Int J Pharm Biomed Sci 2011;2(3):81-5.
Kayabas U, Bayraktar M, Otlu B, et al. An outbreak of Pseudomonas aeruginosa because of inadequatedisinfection procedures in a urology unit: a pulsed-field gel electrophoresis-based epidemiologic study. Am J Infect Control 2008;36(1):33-8.
Ramos GP, Rocha JL, Tuon FF. Seasonal humidity may influence Pseudomonas aeruginosa hospital-acquired infection rates. Int J Infect Dis 2013;17(9):e757-61.
Modarres s, Nassiri Oskoii N. Bacterial etiologic agents of urinary tract infection in children in the Islamic Republic of Iran. East Mediterran Health J 1997;3(2):290-5.
Bitsori M, Maraki S, Koukouraki S, et al. Pseudomonas aeruginosa urinary tract infection in children: risk factors and outcomes. J Urol 2012;187(1):260-4.
Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and Management of Pediatric Urinary Tract Infections. Clin Microbiol Rev 2005;18(2):417-22.
Nickavar A, Sotoudeh K. Treatment and prophylaxis in pediatric urinary tract infection. Int J Prev Med 2011;2(1):4-9.
Takeyama K, Kunishima Y, Matsukawa M, et al.Multidrug-resistant Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infection. J Infect Chemother 2002;8(1):59-63.
Jombo GTA, Jonah P, Ayeni JA. Multidrug resistant pseudomonas aeruginosa in contemporary medical practice: findings from urinary isolates at a nigerian university teaching hospital. Nigerian J Physiol Sci 2008;23:105-9.
Chikwendu CI, Amadi ES, Obi RK. Prevalence and antimicrobial resistance in Pseudomonas aeruginosa and Klebsiella pneumoniae isolates from non-clinical urinesamples. N Y Sci J 2010;3:194-200.
Gençer S, Ak Ö, Benzonana N, et al. Susceptibilitypatterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey.Ann Clin Microbiol Antimicrob 2002;1(1):1-4.
Khajuria A, Praharaj AK, Kumar M, et al. Emergence ofNDM - 1 in the Clinical Isolates of Pseudomonas aeruginosa in India. J Clin Diagn Res 2013;7(7):1328-31.
Moehario LH, Hartono TS, Wardoyo EH, et al. Trend of antibiotics susceptibility of multidrugs resistancePseudomonas aeruginosa in Jakarta and surrounding areas from 2004 to 2010. Afr J Microbiol Res 2012;6:2222-9.
Onguru P, Erbay A, Bodur H, et al. Imipenem- Resistant Pseudomonas aeruginosa: Risk Factors for Nosocomial Infections. J Korean Med Sci 2008;23(6):982-7.
Neuner EA, Sekeres J, Hall GS, et al. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother 2012;56(11):5744-8.
Tsutsui A, Suzuki S, Yamane K, Matsui M, Konda T, Marui E, Takahashi K, Arakawa Y. Genotypes and infection sites in an outbreak of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2011 Aug;78(4):317-22.
Shigemura K, Takase R, Osawa K, et al. Emergence and prevention measures for multidrug resistant Pseudomonas aeruginosa in catheter-associated urinary tract infection in spinal cord injury patients. Spinal Cord 2015;53(1):70-4.
Hamood AN, Griswold JA, Duhan CM. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res 1996;61(2):425-32.
Fazeli N, Momtaz H. Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated from Iranian Hospital Infections. Iran Red Crescent Med J 16(10):e15722.
Nikbin VS, Aslani MM, Sharafi Z, et al. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol 2012;4(3):118-23.
Bradbury RS, Roddam LF, Merritt A, et al. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol 2010;59(Pt 8):881-90.
Mitov I, Strateva T, Markova B. Prevalence of virulence genes among bulgarian nosocomial and cystic fibrosis isolates of Pseudomonas aeruginosa. Braz J Microbiol 2010;41(3):588-95.
Shaver CM, Hauser AR. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004;72(12):6969-77.
Pankhaniya RR, Tamura M, Allmond LR, et al. Pseudomonas aeruginosa causes acute lung injuryvia the catalytic activity of the patatin-like phospholipase domain of ExoU. Crit Care Med 2004;32(11):2293-9.
| Files | ||
| Issue | Vol 54, No 3 (2016) | |
| Section | Original Articles | |
| Keywords | ||
| Pseudomonas aeruginosa Virulence factors Urinary tract infections Pediatrics. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
